14 results
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... Neutropenia LOW RISK ... stable and no medical ... comorbidities HIGH RISK ... #Algorithm #Management
Paucis Verbis card: Early goal directed therapy
April 16th, 2010 | ALiEM Cards, Infectious Disease 
By: Michelle
therapy April 16th, 2010 ... | ALiEM Cards, ... was an absolute risk ... Rivers #Protocol #Algorithm ... #ALiEM
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... Change in clinical ... PCI/DES ( Levine 2016 ... since ACS ( Levine 2016 ... stroke ( Doherty 2017
Malignant Hyperthermia is a very rare, but life-threatening condition that can occur after using certain anesthetic
management #treatment #algorithm ... (2018). ... Johannsen, S. (2014 ... Therapeutics and Clinical ... Risk Management
IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis
Algorithm for the management of acute bacterial rhinosinusitis.
IDSA Clinical Practice ... Rhinosinusitis Algorithm ... Diagnosis #Management #IDSA ... #2012 #Rhinosinusitis ... #Antibiotics #Algorithm
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
GrepMed Handbook Clinical ... immunocompromised, IBD) • ↑Risk ... Lowest Risk: Tetracyclines ... Tx Management (IDSA ... /severe CDI IDSA
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... or those with clinical ... indication by June 2014 ... #SSTIs #Algorithm ... infections #cellulitis #idsa
IDSA Algorithm for Neutropenic Fever - Initial Management, Subsequent Management and Prolonged Fever
Figure 1. Initial management
IDSA Algorithm for ... stable and no medical ... >7 days or • Clinically ... neutropenic #fever #IDSA ... #Algorithm #Management
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
Fatigue and IBD Algorithm ... fatigue despite clinical ... remission • Risk ... IBD Pearls: • IDA ... differentiate IDA
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Indication: Reduce risk ... Inhibitor GOLD 2019 ... Dosing: 250 mcg tablet ... to reduce the risk ... won’t have any clinical